Grifols Achieves Its “Best Score” in the S&P Global Sustainability Ranking

Grifols has achieved its “best score” in the S&P global sustainability ranking with seventy points, which represents an increase of seven points compared to last year’s results. In a statement on Tuesday, the company said that the result highlights its “significant progress” and its commitment to sustainability.

The ranking has recognized Grifols’ commitment to human rights, supply chain management, climate change management, and health and safety. Specifically, it has rewarded the company’s efforts to promote a more responsible and sustainable supply chain, as well as its progress in climate strategy and risk management.

In terms of social strategy, S&P has recognized Grifols’ commitment to ensuring a safe and healthy workplace for employees, in addition to its defense and promotion of human rights.

Grifols is keeping an eye on Brookfield’s takeover bid

In parallel, the Canadian firm Brookfield Asset Management asked the board of directors of Grifols for more time at the end of September to analyse the takeover bid that it is preparing together with the founding family for the Catalan firm.

The blood derivatives company declined to comment on this request from the Brookfield fund, which has been “immersed” in due diligence since last July, when the then executive president of Grifols, Thomas Glanzmann, announced that it had already begun.

According to the same sources, Brookfield announced that it would send a letter to Grifols “to request an extension to complete its review of the company,” as reported by Bloomberg. This announcement came after the National Securities Market Commission (CNMV) had opened a disciplinary file against Grifols for defects in financial information and management reports.

__

(Featured image by Joshua Golde via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us